Recombinant multi-species UGT2B7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UGT2B7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]
The Alternative Names of target: 3,4-catechol estrogen-specific UDPGT,UDP-glucuronosyltransferase 2B7,UDP-glucuronosyltransferase 2B9 (UDPGT 2B9),UDPGT 2B7,UDPGT 2B9,UDPGT2B7,UDPGTH2,UDPGTh-2,UGT2B7,UGT2B9

Target products collectionGo to UGT2B7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2239-Ag-1/ GM-Tg-hg-IP2239-Ag-2 Human UGT2B7 protein Human
GM-Tg-rg-IP2239-Ag-1/ GM-Tg-rg-IP2239-Ag-2 Rat UGT2B7 protein Rat
GM-Tg-mg-IP2239-Ag-1/ GM-Tg-mg-IP2239-Ag-2 Mouse UGT2B7 protein Mouse
GM-Tg-cynog-IP2239-Ag-1/ GM-Tg-cynog-IP2239-Ag-2 Cynomolgus/Rhesus macaque UGT2B7 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2239-Ag-1/ GM-Tg-felg-IP2239-Ag-2 Feline UGT2B7 protein Feline
GM-Tg-cang-IP2239-Ag-1/ GM-Tg-cang-IP2239-Ag-2 Canine UGT2B7 protein Canine
GM-Tg-bovg-IP2239-Ag-1/ GM-Tg-bovg-IP2239-Ag-2 Bovine UGT2B7 protein Bovine
GM-Tg-equg-IP2239-Ag-1/ GM-Tg-equg-IP2239-Ag-2 Equine UGT2B7 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2239-Ag-1/ GM-Tg-hg-IP2239-Ag-2; GM-Tg-rg-IP2239-Ag-1/ GM-Tg-rg-IP2239-Ag-2;
GM-Tg-mg-IP2239-Ag-1/ GM-Tg-mg-IP2239-Ag-2; GM-Tg-cynog-IP2239-Ag-1/ GM-Tg-cynog-IP2239-Ag-2;
GM-Tg-felg-IP2239-Ag-1/ GM-Tg-felg-IP2239-Ag-2; GM-Tg-cang-IP2239-Ag-1/ GM-Tg-cang-IP2239-Ag-2;
GM-Tg-bovg-IP2239-Ag-1/ GM-Tg-bovg-IP2239-Ag-2; GM-Tg-equg-IP2239-Ag-1/ GM-Tg-equg-IP2239-Ag-2
Products Name UGT2B7 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name UGT2B7
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UGT2B7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.